Breast cancer is less likely to be detected through a routine cancer screening for women with multiple sclerosis (MS), while colorectal cancer is more likely to be detected at an early stage in MS patients compared with those without the disease, a Canadian study found. “Understanding the pathways to earlier…
People with multiple sclerosis (MS) are at greater risk of developing cancer than the general population, according to a French study involving nearly 100,000 patients. This increased risk was particularly apparent for prostate, breast, colorectal, and anal cancers, as well as cancers of the trachea, bronchus, and lung. The researchers…
Women with multiple sclerosis (MS) diagnosed with breast cancer are not at a higher risk of dying from cancer than women without the neurodegenerative disorder, according to a Canadian population-based study. However, 10 years after their breast cancer diagnosis, women with MS were 28% more likely to die from any…
People with multiple sclerosis (MS) are at a higher risk of developing and dying from bladder cancer than people without the neurodegenerative disorder, according to a Canadian population-based study. However, no differences were found between MS patients and unaffected individuals in terms of their risk of breast and…
Treatment of multiple sclerosis (MS) patients with rituximab does not increase breast cancer risk in women, and is not associated with a higher risk for malignant cancer of any type in men or women, when compared to Gilenya (fingolimod) or Tysabri (natalizumab), according to a nationwide study in…
Multiple sclerosis (MS), especially in premenopausal women, does not seem to be associated with breast cancer, as suggested in previous studies, researchers reported. And, they argue, the higher incidences of this cancer in postmenopausal women with MS may be due more to surveillance bias than true risk. These findings were detailed in the study, “…
Tamoxifen (brand name, Nolvadex), a widely used treatment for breast cancer, can also be used to treat myelin loss in patients with multiple sclerosis (MS), a new study suggests. The finding, by a team of researchers at the University of Cambridge, U.K., was published in a study titled “…
Get regular updates to your inbox.